Docetaxel monotherapy as second-line treatment for pretreated advanced non-small cell lung cancer patients.
Ko YH, Lee MA, Hong YS, Lee KS, Park HJ, Yoo IeR, Kim YS, Kim YK, Jo KH, Wang YP, Lee KY, Kang JH.
Ko YH, et al. Among authors: lee ma, lee ks, lee ky.
Korean J Intern Med. 2007 Sep;22(3):178-85. doi: 10.3904/kjim.2007.22.3.178.
Korean J Intern Med. 2007.
PMID: 17939335
Free PMC article.